Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease
Inflamm Bowel Dis
.
2023 Sep 1;29(9):e37.
doi: 10.1093/ibd/izad088.
Authors
Lauren Loeb
1
,
Ayan Nasir
1
,
Michael F Picco
2
,
Jana G Hashash
2
,
Jami A Kinnucan
2
,
Francis A Farraye
2
Affiliations
1
Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
2
Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
PMID:
37196096
DOI:
10.1093/ibd/izad088
No abstract available
Publication types
Letter
Comment
MeSH terms
Biological Products* / therapeutic use
Crohn Disease*
Humans
Inflammatory Bowel Diseases* / drug therapy
Prior Authorization
Substances
Biological Products